Epigenetic Therapeutic Targets Summit

Kongressthemen
Returning for its second year, the virtual Epigenetic Therapeutic Targets Summit is the first-ever industry forum dedicated exclusively to the frontier of drug development in epigenetics.

The two-day program will enable you to:

Explore the full spectrum oncological and non-oncological applications of genetic regulation therapeutics that is being investigated to identify new unmet clinical needs that epigenetics could be central to treating.

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
Brochure: https://go.evvnt.com/742339-3?pid=4832

Speakers: Ellen Filvaroff, Executive Director in Translational Development, Bristol-Myers Squibb, Elisabetta Chiarparin, Director - Medicinal Chemistry, AstraZeneca and more

https://go.evvnt.com/742339-2?pid=4832

Herr Customer Service